{"id":"W4384925159","doi":"10.1186/s12967-023-04329-7","title":"Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)","year":2023,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"EMD Serono; Genentech; National Institutes of Health; Eisai; MacroGenics; Moderna; Apellis Pharmaceuticals; Incyte; Sanofi; Exelixis; Regeneron Pharmaceuticals; Gilead Sciences; BeiGene; Bristol-Myers Squibb; AstraZeneca; Celldex Therapeutics; Amgen; University of Texas MD Anderson Cancer Center; Pfizer; National Cancer Institute; Emory University","keywords":"Immunotherapy; Medicine; Immune system; Cancer immunotherapy; Melanoma; Adoptive immunotherapy; Immunology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002857697,0.0017093,0.0006237508,0.0008347171,0.000781956,0.003015474,0.0009608329,0.005997026,0.03249149],"category_scores_gemma":[0.001424065,0.0003654025,0.001003956,0.0004310744,0.0003965514,0.001793856,0.001631797,0.005499243,0.01985177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001404846,"about_ca_system_score_gemma":0.003105047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001474721,"about_ca_topic_score_gemma":0.003259724,"domain_scores_codex":[0.9988943,0.0001578592,0.00006194187,0.0001795528,0.0004118193,0.000294678],"domain_scores_gemma":[0.9981886,0.0001367864,0.00008956761,0.00003085453,0.0005127008,0.001041403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001289783,0.00006187303,0.0001408248,0.000222443,0.00000804204,0.0001611559,0.00001315954,0.00005667093,0.000733075,0.0004436754,0.9630303,0.03499974],"study_design_scores_gemma":[0.00003438017,0.00007209476,0.0007779767,0.0001436156,0.000009176632,0.0001484627,0.00003146342,0.00005186541,0.000282494,0.0003039126,0.9981354,0.000009223036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.002091323,0.2103618,0.001307228,0.2551902,0.4743738,0.0004066173,0.001492739,0.0002126539,0.05456356],"genre_scores_gemma":[0.01219196,0.1410753,0.002642806,0.120386,0.3431572,0.0004279214,0.002690634,0.000214079,0.3772141],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03249149,"threshold_uncertainty_score":0.1086949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05524501084084582,"score_gpt":0.3626893568225062,"score_spread":0.3074443459816604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}